We’ve written about skin patch biosensors in a range of applications from UV exposure detection to atrial fibrillation monitoring. Researchers and medical device and supply companies investigating skin patch wearables focus on the advantages of the patch form factor, especially for applications that benefit from continuous biomarker tracking.
IDTechEx Research recently published a market research report Electronic Skin Patches 2018-2028 that takes a decade-long view of the emerging technology. The report encompasses information on 26 application areas, more than 85 companies, and 95 case studies. The report uses market history and forecast data to predict that skin patch electronic wearable revenues will exceed $10 billion by 2023 and reach nearly $15 billion by 2028.
Because skin patches enable precise device positioning and constant skin contact, the technology is particularly advantageous for diabetes management and cardiovascular monitoring, according to the report’s authors. Compared to smartwatches, for example, electronic skin patches provide better data quality for at-risk ambulatory heart patients. Skin patch applications for people with diabetes include continuous glucose monitoring (CGM) and insulin pumps, forming a closed-loop system when used together. The IDTechEx report dives deep into both of these two medical applications, focusing on product types, technologies, and strategies.